单位:[1]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.[2]Department of Thyroid and Breast Surgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.外科学系甲状腺乳腺外科华中科技大学同济医学院附属同济医院
The authors thank the National Cancer Institute, Information Management Services, and SEER program
registries for the creation and maintenance of the database. This work was supported by the China National
Key R&D (or Research and Development) Program (No. 2020AAA0105000 and 2020AAA0105004), the Natural Science Foundation of China (No. 82173328), the Natural Science Foundation of China (No. 81872160),
the Natural Science Foundation of China (No. 82072940), the Natural Science Foundation of China (No.
82103047), the Natural Science Foundation of China (No. 82102887), the CAMS Innovation Fund for Medical Sciences (CIFMS) (No. 2021-I2M-C&T-A-012), the CAMS Innovation Fund for Medical Sciences (CIFMS)
(No. 2021-I2M-C&T-B-044), the CAMS Innovation Fund for Medical Sciences (CIFMS) (No. 2022-I2M-C&TB-087), the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (No. 2022-
JKCS-04), the Beijing Association for Science and Technology’s ‘‘Golden-Bridge Seed Funding Program’’
(No. ZZ22027), the Beijing Hope Run Special Fund of Cancer Foundation of China (No. LC2020L01), the Beijing Hope Run Special Fund of Cancer Foundation of China (No. LC2019L07), the Beijing Hope Run Special
Fund of Cancer Foundation of China (No. LC2022A19), the Chinese Young Breast Experts Research project
(No. CYBER-2021-005), the XianSheng Clinical Research Special Fund of China International Medical Foundation (No. Z-2014-06-2103), the Beijing Xisike Clinical Oncology Research Foundation (No. Y-Young2021-
0017), and the Beijing Xisike Clinical Oncology Research Foundation (No. Y-NESTLE2022QN-0018). The
graphical abstract was draw by Figdraw (https://www.figdraw.com/).
第一作者单位:[1]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Liu Qiang,Zhang Wenxiang,Li Qi,et al.Risk of cerebrovascular disease after cancer diagnosis in the United States[J].ISCIENCE.2023,26(7):doi:10.1016/j.isci.2023.107165.
APA:
Liu Qiang,Zhang Wenxiang,Li Qi,Chen Li,Wang Xiangyu...&Wang Jing.(2023).Risk of cerebrovascular disease after cancer diagnosis in the United States.ISCIENCE,26,(7)
MLA:
Liu Qiang,et al."Risk of cerebrovascular disease after cancer diagnosis in the United States".ISCIENCE 26..7(2023)